Ellenbogen Michael 4

4 · Evolv Technologies Holdings, Inc. · Filed Mar 3, 2026

Form 4

Period: 2026-03-01

Director

Transactions

Exercise/Conversion
Class A Common Stock
2026-03-01+57,392→ 2,141,353 total
Exercise/Conversion
Class A Common Stock
2026-03-01+50,505→ 2,191,858 total
Exercise/Conversion
Class A Common Stock
2026-03-01+66,787→ 2,258,645 total
Sale
Class A Common Stock
[F1][F2]
2026-03-02$5.19/sh−82,913$430,318→ 2,175,732 total
Exercise/Conversion
Restricted Stock Units
[F3][F4]
2026-03-01−66,787→ 0 total
→ Class A Common Stock (66,787 underlying)
Exercise/Conversion
Restricted Stock Units
[F3][F5]
2026-03-01−57,392→ 57,392 total
→ Class A Common Stock (57,392 underlying)
Exercise/Conversion
Restricted Stock Units
[F3][F6]
2026-03-01−50,505→ 101,010 total
→ Class A Common Stock (50,505 underlying)

Holdings

Footnotes (6)

[F1]The sale reported in the Form 4 was effected solely with the intent to cover withholding taxes in connection with the vesting of RSUs.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.19 to $5.29. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date.
[F4]The RSUs vest in three equal annual installments commencing on March 1, 2024.
[F5]The RSUs vest in three equal annual installments commencing on March 1, 2025.
[F6]The RSUs vest in three equal annual installments commencing on March 1, 2026.

Signature

/s/ Rachel Roy, Attorney-in-fact for Michael Ellenbogen|2026-03-03

Documents

1 file